SIBIONICS Unveils AI-Powered GS3 Glucose Sensor at Melbourne Diabetes Congress
September 03, 2026 – Melbourne -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne, held August 18-21 and featuring a company booth, a scientific symposium and on-site interviews with certified diabetes educators (CDEs).
GS3 sensor delivers 14-day monitoring with a 2.9mm profile
The factory-calibrated GS3 sensor is designed for continuous glucose tracking over a 14-day cycle while minimizing physical discomfort through its slim 2.9mm profile. SIBIONICS positioned the device as an extension of its work in brain-computer interfaces, including a retinal prosthesis for patients with retinitis pigmentosa, adapting high-precision biosensor and signal-processing engineering into a more accessible CGM platform.
